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Abstract
Today, clinical data is routinely recorded in vast amounts, but 
its reuse can be challenging. A secondary use that should ide-
ally be based on previously collected clinical data is the com-
putation of clinical quality indicators. In the present study, we 
attempted to retrieve all data from our hospital that is re-
quired to compute a set of quality indicators in the domain of 
colorectal cancer surgery. We categorised the barriers that 
we encountered in the scope of this project according to an 
existing framework, and provide recommendations on how to 
prevent or surmount these barriers. Assuming that our case is 
not unique, these recommendations might be applicable for 
the design, evaluation and optimisation of Electronic Health 
Records.
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Introduction
Today, increasing volumes of clinical data are being routinely 
recorded and stored in Electronic Health Records (EHRs). The 
potential benefit from reusing the resulting data sources is 
enormous, both for individual patients and society in general. 
In fact, according to a recent report by PricewaterhouseCoop-
ers [1], using data for secondary purposes is one of the most 
promising ways to improve health outcomes and costs. Such 
purposes comprise clinical research, the recruitment of eligible 
patients for clinical trials, the early detection of epidemics, 
reimbursement, clinical audit, the generation or testing of 
medical hypotheses and quality monitoring or reporting based 
on clinical quality indicators. However, reusing clinical data is 
often challenging in practice.
The Dutch government releases sets of both legally mandatory
and voluntary evidence-based quality indicators for various 
kinds of diseases and interventions. The government requests 
indicator results for entire reporting years to monitor and 
compare the quality of care. These indicators typically require 
data from several sources and are often computed manually, 
which is error-prone and time-consuming. To enable timely 
feedback and, where necessary, intervention inside hospitals,
the indicators should be computed automatically and in real-
time, based on routinely recorded clinical data. For a recent 
study, we strove to gather all raw source data required to com-
pute a set of indicators for the Gastrointestinal Oncology Cen-
tre Amsterdam (GIOCA). 
The GIOCA is a specialised outpatient clinic that has been set 
up to improve the quality of care for patients with (suspected) 
cancer of the gastrointestinal tract. Patients who register at the 
GIOCA are scheduled for an appointment within only seven 
days at most. During this appointment, examinations to diag-
nose the patient are carried out, the case is discussed in a mul-
tidisciplinary meeting, and a detailed treatment plan is estab-
lished and communicated to the patient. As this patient-
centred rapid diagnosis process reduces the time until treat-
ment starts, the founders of the GIOCA are motivated to 
measure its performance. We chose the domain of colorectal
cancer surgery because it is also the subject of the recently 
founded Dutch Surgical Colorectal Audit (DSCA) [2]. The 
DSCA collects all data items necessary to compute the set of 
indicators. These data items are currently being entered manu-
ally by one of our surgeons, but ideally, they would be pre-
populated from the underlying information systems, reviewed 
by the surgeon and then submitted to the DSCA. The GIOCA 
uses the same information systems as other departments of our 
hospital, plus additional spreadsheets for internal administra-
tion and management. 
The goal of this paper is to report on the barriers that we en-
countered in the attempt to gather all raw source data required 
to compute the set of indicators. We categorised these barriers 
and provide recommendations on how they could be prevented 
or surmounted. A part of these recommendations can support 
the design of our hospital’s new EHR. Supposing that our ex-
periences are similar to data reuse projects in many hospitals,
we assume that these recommendations might also help to 
design, evaluate and optimise systems in other hospitals. 
Methods
With the explicit consent and support of the management of 
the GIOCA, we cooperated with our hospitals’ general ICT 
service in order to retrieve the data required to compute the set 
of four clinical quality indicators in the domain of colorectal 
cancer surgery (the same set as employed in [3]) for the re-
porting years 2010 and 2011. The indicators are contained in 
the sets released by the governmental program Zichtbare Zorg 
and the Dutch Healthcare Inspectorate [4], [5]: 
I1: Number of examined lymph nodes after resection (pro-
cess indicator)
Numerator: Number of patients who had 10 or more lymph 
nodes examined after resection of a primary colon carcinoma.
Denominator: Number of patients who had lymph nodes ex-
amined after resection of a primary colon carcinoma.
Exclusion criteria: Previous radiotherapy and recurrent colon 
carcinomas. 
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I2: Participation in Dutch Surgical Colorectal Audit (DSCA) 
(process indicator)
Numerator: Number of surgical resections of a colorectal car-
cinoma situated in colon or rectum (only count primary carci-
nomas) for which data has been submitted to the Dutch Surgi-
cal Colorectal Audit.
Denominator: Total number of surgical resections of a colo-
rectal carcinoma situated in colon or rectum (only count pri-
mary carcinomas).
I3: Patients with rectum carcinoma who have been discussed 
in a preoperative multidisciplinary meeting (process indica-
tor)
Numerator: Number of patients with rectum carcinoma who 
have been discussed in a preoperative multidisciplinary meet-
ing.
Denominator: Number of patients with rectum carcinoma op-
erated in the reporting year.
Inclusion criterion: Patients who have been operated in the 
reporting year due to a rectum carcinoma.
Exclusion criteria: Transanal Endoscopic Microsurgery 
(TEM) resections and recurrent rectum carcinomas. The Dutch 
Surgical Colorectal Audit states that the presence of a radiolo-
gist, a radiotherapist, a surgeon, an oncologist, a colon, stom-
ach and liver physician and a pathologist are required for a 
preoperative multidisciplinary meeting.
I4: Unplanned re-interventions after resection of a primary 
colorectal carcinoma (outcome indicator)
Numerator: Number of re-interventions during the same ad-
mission or during 30 days after the resection (choose longest 
interval) in the reporting year.
Denominator: Total number of primary resections of a colo-
rectal carcinoma during the reporting year.
Inclusion criteria: Primary colorectal carcinoma = first presen-
tation of a colorectal carcinoma (thus not recurrent); might be 
the second or next primary presentation.
Exclusion criteria: Transanal Endoscopic Microsurgery 
(TEM); endoscopic and open polypectomy. 
This indicator comes with a list of definitions: 
Resection: surgical removal of colon segment where the colo-
rectal carcinoma is situated. 
Re-intervention: re-operation in the abdomen or an interven-
tion during which a complication in the abdomen is being 
treated (inclusive percutaneous incision and drainage, drain-
age via rectum, embolization of bleedings in the abdomen, et
cetera). 
Admission: the time the patient spends in a hospital directly 
after the operation (the same hospital or another one where the 
patient has been referred), can be longer than 30 days. 
Our hospital’s general ICT service was currently in the pro-
cess of investigating the requirements for setting up an opera-
tional data store (ODS), which integrates data from several 
operational databases. As the ICT service was especially in-
terested in investigation of typical data collection require-
ments from a business intelligence perspective, we started a
joint project to gather the required data. 
In the absence of a central overview of the data available in 
our hospital, the goal of the first phase of the project was to 
identify the original sources of the required “raw” data ele-
ments, i.e. whether and in which systems these elements are 
stored, and who are the responsible contact persons. In order 
to do so, we interviewed the experts who are treating colorec-
tal cancer patients, observed the work- and data flows, and 
interviewed those responsible for computation of the quality 
indicators as well as potentially responsible contact persons. 
In the second phase of the project, the team from our hospi-
tals’ general ICT service worked on the technical design of the 
ODS and on the actual data retrieval from the various data-
bases. For each of the data elements established in the first 
phase, they identified its name, type, format and length in the 
database, and whether it was optional or mandatory. After this 
phase was completed, we obtained a version of the required 
data. In the third phase of the project, we analysed the data 
obtained and identified several quality issues that impeded its 
reuse.
We documented all barriers encountered in the course of this 
process, and - based on consensus - categorised them accord-
ing to Galster’s framework of causes that impede the reuse of 
clinical data in clinical settings [6]. Galster’s categorisation is 
based on a literature review and shown in Figure 1. The causes 
are linked to underlying aspects that have been indicated in the 
Semantic Health Report [7], i.e. technical, organisational, le-
gal and medical aspects. We also categorised the encountered 
barriers according to these underlying aspects, as well as the 
phases of our project. 
Our hospital’s Institutional Review Board waived the need for 
informed consent, as individual patients were not directly in-
volved. The use of the data is officially registered according to 
the Dutch Personal Data Protection Act.
Results 
Required data
In the first phase of our project, we identified 12 data elements 
required to compute the set of 4 quality indicators. After inter-
viewing more than 15 people, including staff members of the 
GIOCA, those responsible to compute the set of quality indi-
cators, and various database administrators, we identified 9 
corresponding source systems as shown in Table 1. All re-
quired data elements were stored in a structured digital format, 
except for relations between diagnoses and procedures, which 
Figure 1-Galster's Framework of reasons why clinical data is not reused.
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are essential to identify procedures that have been carried out 
for colorectal carcinomas and not for other reasons. These 
relations are often documented in free-text descriptions such 
as surgery reports. Most of the identified source systems were 
stand-alone systems for clinical and administration purposes, 
with data flows between them. For example, high-detail data 
from the surgical procedure system flows in less detail into the 
central procedure register. Two of the sources are external 
national registers. Please note that several items occurred in 
several databases, and in principle, one source per item should 
be sufficient to compute the quality indicators. As we strived 
to identify the source system with the highest data quality, our 
initial goal was to retrieve the required data from all identified 
systems. 
The second phase of our project resulted in 5 delivered data-
base tables after 8 months, which are underlined in Table 1. 
We analysed their quality in the third phase.
Barriers to the reuse of routinely recorded clinical data
In this section, the barriers we encountered are categorised 
according to Galster’s framework as shown in Figure 1, and 
according to the three phases of our project.
A) Data not available when or where it is needed
Hindered access to data sources (technical and organisational 
reasons), second phase.
The only way to obtain data from the nationwide histopathol-
ogy and cytopathology pchive was to request and receive it via 
email. Furthermore, some of the databases in our hospital are 
administered by external providers, which do not always guar-
antee structured and real-time access to our databases.
B) Data present, but usage of the source is prohibited
Patient Numbers (legal reasons), third phase.
The use of data was officially registered according to the 
Dutch Personal Data Protection Act, under the condition that it 
was de-identified. Therefore, we received the required data 
from our hospital’s source systems with patient numbers
hashed by the ICT service. In a later phase of our project, we 
could not use these patient numbers to match the patient data 
with data from our hospital’s data warehouse, which uses oth-
er hashed patient numbers. Of course, this problem would not 
have existed if the ICT service and the administrators of the 
data warehouse had matched the data for us. 
C) Data present but not routinely used in its available form
Organisational / Cultural Barriers (organisational reasons), 
first and second phase.
In our university hospital, we encountered various barriers in 
the attempt to obtain data for reuse that seemed to be due to 
insufficient prioritisation and culture of data reuse. First of all, 
no standard procedure existed to process data requests such as 
ours. Data can be requested via the ICT service, as in our pro-
ject, or directly via the database administrators. In the busy 
environment of the ICT department responsible for critical IT 
systems, our project did not receive the highest priority, which 
may have caused some delay. Also, the composition of the 
team changed several times during the project, hampering 
smooth communication and progress. Once we identified the 
relevant source systems and the corresponding responsible 
persons, there were no clear guidelines and procedures on how 
to request a database extract; rather, this issue had to be dis-
cussed with every database administrator individually.
Another major problem was that no central overview of the 
various data sources, their governance and content, including 
employed code systems and data dictionaries, existed, and that 
the management of our hospital did not envisage such an 
overview.
Insufficient quality (organisational reasons), third phase.
Analysing the database tables that we received from the ICT 
service, we encountered the following quality issues.
 Incompleteness on database level.
We did not receive any data on radiotherapy. For 
double-recorded elements (e.g. two sources for mul-
tidisciplinary meetings, which are recorded in the 
EHR, but due to the setup of the GIOCA can also be 
inferred from the patient’s first visit), we received 
only one of the sources. Additionally, we encoun-
tered a problem that can probably not be generalised
to other hospitals. The dataset did not include data for 
a complete reporting year, which would have been 
essential as quality indicators are computed per re-
porting year. We received data for 2010 and 2011, 
but for 2010 information on lymph node examina-
tions and multidisciplinary meetings was missing, 
while for 2011, information on admission and dis-
charge dates was missing.
 Incompleteness on data element level.
Table 1-Required data items and their source systems
Data Element Source System Indicator
Surgical procedure: date, type, anatomic location Surgical procedure system,
procedure register
I1, I2, I3, I4
Diagnosis: anatomic location, type (primary, 
recurrent)
Diagnosis register I1, I2, I3, I4
Radiotherapy: date Radiotherapy system, 
appointment register, 
Procedure register
I1
Lymph node examination: date, number of 
examined lymph nodes (in pathology report)
Nationwide histopathology and 
cytopathology data archive
I1
Surgical procedure submitted to Dutch Surgical 
Colorectal Audit (DSCA)
National register I2
Preoperative multidisciplinary meetings: date EHR, appointment register I3
Admission: admission and discharge date Admission register I4
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While the surgical procedure data was delivered for 
both reporting years, it was probably incomplete, 
with the last surgical procedure of the year 2011 be-
ing on the 16th of December. Furthermore, around 
half of the multidisciplinary meetings had no date 
recorded, and were therefore unusable.
 Incorrectness.
Some data elements were obviously incorrect, such 
as dates in the far future (e.g. year 2101).
 Lack of interlinking of data in various sources.
To reuse data for indicator computation, it is essential 
to know which procedures have been carried out for 
which diagnoses, but these relations are not recorded 
in our hospital in a structured format. The only rela-
tion between the different data sources is the (hashed) 
patient number.
 Missing provenance of data.
To reuse data, its provenance might be of interest, 
especially when data can stem from several sources. 
However, the data that we received did not contain 
any provenance information, so that we had to 
schedule further meetings to obtain a clear overview.
 Lack of inside-knowledge of “meaning of data”.
Our hospital employs national and local code systems 
instead of international standard terminologies, and a 
central metadata registry is absent, making it hard to 
identify the meaning of the respective data elements. 
For example, we encountered diagnosis-treatment 
codes such as 3314, 554 or 11, diagnosis codes such
as 13862, 29798, 7155, and specialisations such as 
KGA, AUD or KEC. Likewise, procedure codes such 
as 335127, 989899 or 338533Y were not interpretable 
without knowledge of the coding system.
Problem of selecting patients in one system and querying their 
data in another system (technical reasons), third phase.
Our hospital’s data infrastructure is based on several small 
source systems instead of one large system, which makes the 
execution of queries - which are automatically optimised for 
integrated systems - harder. When querying several systems, 
one has to identify a suitable starting point to obtain a basic set 
of relevant patients, and then query other systems based on the 
identified patient numbers. However, it might not always be 
clear which one is the most suitable system to start with, and 
querying separate datasets can lead to a large number of irrel-
evant results. With regard to colorectal surgery indicators, for 
example, we would search for all patients who had a colecto-
my or a resection of rectum due to a colorectal carcinoma. In 
order to do this, we must query the surgical procedure data-
base for all patients with relevant procedures and the diagnosis 
database for all patients with a colorectal carcinoma, and then 
construct the intersection of both query result sets.
D) Data apparently present, but in the specific situation it is 
considered inadequate
Because the data did not cover a complete reporting year, we 
did not attempt to compute the set of indicators, and therefore 
did not analyse the relevance and reliability of the data. We 
assume that all data was relevant, but that we might have en-
countered reliability issues, including obviously wrong proce-
dure years such as 2101. Reliability issues are especially visi-
ble when data is recorded twice instead of being reused, such 
as in our hospital and in the DSCA, and double recorded items 
are inconsistent. We are currently investigating such issues in 
a subsequent study. 
Discussion
Main findings
In our study, we identified a number of barriers that hinder the 
(timely) reuse of routinely collected clinical data. Even though 
all data that we required was in principle available in a digital 
format, and most of it within our hospital, it took a long time
until we received a version of the requested data, and the data 
itself was of insufficient quality. The barriers that we identi-
fied cover all four of Galster’s categories of why clinical in-
formation is not reused. However, category C, “Data present 
but not routinely used in its available form,” contained the
most problems, mainly due to underlying organisation-
al/cultural and data quality reasons.
Due to the identified data quality issues, we proceeded in 
gathering the required data ourselves, with the explicit consent 
of both our hospital’s ICT service and the management of the 
GIOCA. We started using our freshly launched hospital-
internal data warehouse for research, which turned out to satis-
fy our requirements, with two exceptions: the data items radi-
otherapy and multidisciplinary meeting. We made contact 
with another data gathering and analysis initiative in the scope 
of the GIOCA, which already gathered radiotherapy and mul-
tidisciplinary meeting data and willingly shared it with us, so 
that we finally had a solid basis to compute first quality indi-
cators.
Related Work
Holzer and Gall [8] compiled a catalogue of eight core re-
quirements for secondary use of EHRs. Because the authors 
follow a document-oriented approach to data reuse (as op-
posed to our structured database-oriented approach), most of 
their core requirements, such as “possibility to formulate que-
ries within the retrieved documents” cannot be related directly 
to our findings. However, other requirements, such as “use of 
standards and terminologies” fit ours.
Prokosch and Ganslandt [9] identify three challenges in the 
context of reusing EHRs for clinical research: to establish 
comprehensive clinical data warehouses that can be harvested 
with data mining methods, to establish an IT infrastructure 
that supports clinical research and to integrate and link medi-
cal record systems and clinical trial databases. We argue that 
data warehouses are advantageous but not imperative if source 
systems can be accessed directly, and also support the claim 
that a hospital’s IT infrastructure should support clinical re-
search. Their last challenge - to link medical record systems 
and clinical trial databases - falls outside the scope of our 
study. 
Ancker et al. [10] observed that secondary use of data might 
require a higher degree of data integrity than the original pri-
mary use. The Semantic Health Report [7] claims that to fully 
realise the potential of EHR systems, the data they contain 
should be of high quality, and that timely and secure access to 
those entitled has to be ensured. To reuse clinical data, sys-
tems must be able to exchange data, preserving its meaning. 
These requirements are also reflected in our recommendations 
that we compiled based on the barriers that we encountered.
Strengths and limitations
It might be regarded as a limitation of this study that it includ-
ed only one hospital. However, we assume that our project can 
be seen as analogous to data reuse projects in many hospitals, 
which are likely to encounter similar problems and barriers, 
and therefore might profit from our recommendations.
It is also questionable to what extent the computation of quali-
ty indicators is typical for general data reuse. We argue that 
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the general challenge that characterised our project was to 
retrieve high-quality data from several sources within and 
outside our hospital, and we assume that this challenge under-
lies most data reuse projects. Real-time access to clinical data 
and integration of feedback with EHRs is a further challenge, 
which would not only be desirable for the computation of 
quality indicators, but also indispensable for secondary uses 
such as clinical decision support. 
Recommendations 
Ensure availability of data and accessibility of data sources
When choosing external providers for EHR systems, data ac-
cessibility and reuse should be considered in order to avoid 
“data silos”, in which it is easy to insert data, but hard to ex-
tract it. Likewise, only copies of high-quality local data should 
be submitted to external registers, ensuring the hospital’s 
ownership of the data.
Ensure patients’ interests, privacy and security while allow-
ing for re-use
Even though this is not a direct finding of our study, it should 
be noted that the patients’ rights, privacy and security must be 
protected. Patient data should always be de-identified, unless 
the patients’ identity is absolutely necessary and of high value, 
such as in the recruitment of eligible patients to clinical trials, 
which might require informed consent. 
Set-up a reuse-friendly organisation and culture 
Especially in university hospitals, data reuse should be priori-
tised, and this prioritisation should be part of the hospital cul-
ture. Standard procedures should be set up to request data for 
reuse and financial resources should be made available to ex-
tract data for research that might benefit both the hospital and 
its patients. In order to facilitate reuse, a central overview of 
available data sources should be administered, including their 
governance and content as well as employed code systems and 
data dictionaries. Such a metadata registry could for example 
be based on ISO/IEC 11179, an international standard for rep-
resenting metadata.
Increase data quality 
Data quality comprises completeness and correctness, but also 
the recording of relations between diagnoses and procedures, 
and the use of standard terminologies and information models 
that enable meaning-based retrieval and facilitate the “Collect 
once, use many” paradigm [11]. In order to increase the quali-
ty of elements that are required for reuse, those responsible for
recording the respective elements should be made aware of 
foreseeable secondary uses. Data quality also comprises 
metadata and provenance. In the scope of our project, it would 
have been helpful to know which systems the data stemmed 
from, as well as who recorded the data, and when and why it 
was recorded. 
Allow for cross-database querying 
While one monolithic overarching hospital-internal EHR 
might be desirable, in practice, the IT infrastructures of many
hospitals consist of several dedicated source systems. In prin-
ciple, this should not be a problem as long as data in all sys-
tems can be accessed and seamlessly integrated. However, 
querying several systems is harder and in our case required 
manual work. The ability to execute hospital-wide federated 
queries would alleviate this barrier.
Conclusion
In this paper, we categorised barriers encountered in the at-
tempt to reuse data from our hospital for clinical indicator 
computation and provide recommendations that might support 
the design, evaluation and optimisation of EHRs. Patient data 
can be considered one of the most valuable resources that a 
hospital has at its disposal, and therefore its reuse should be 
facilitated while preserving the patient’s privacy, security and 
interest.
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